# Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

> **NCT03282435** · PHASE1 · UNKNOWN · sponsor: **Dalian University** · enrollment: 30 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** CIK cells with PD-1 blocking
- **OTHER:** standard lung cancer treament
- **BIOLOGICAL:** CIK cells without PD-1 blocking

## Key facts

- **NCT ID:** NCT03282435
- **Lead sponsor:** Dalian University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01
- **Primary completion:** 2023-01
- **Final completion:** 2023-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282435, "Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03282435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*